Cellulitis with Decreased Consciousness
DOI:
https://doi.org/10.57214/jka.v9i2.984Keywords:
Cellulitis, Hygiene Management, Multidisciplinary Therapy, Sepsis Prevention, Uncontrolled DiabetesAbstract
Cellulitis is a bacterial skin and subcutaneous infection caused by the disruption of the skin barrier, immune dysfunction, and/or circulation disorders. It has various risk factors, one of which is uncontrolled diabetes mellitus. Hygiene is also crucial for prevention and long-term management to prevent reinfection. A 52-year-old male presented with decreased consciousness 2 days prior admission. He also had bulla, edema, and pain in his right lower limbs. He had a history of uncontrolled diabetes mellitus. He appeared severely ill with a Glasgow Coma Scale (GCS) of 8 (E2M4V2), hypotension, and tachycardia. At 1/3 distal right cruris and right dorsum of the foot, there were erythematous and ill-defined red-to-purplish black hyperpigmentation with multiple plaque-sized bullae with irregular margins and warmth on palpation. The laboratory examination demonstrated hyperglycemia (733 mg/dL). He was treated in the Intensive Care Unit (ICU) with multidisciplinary therapy. Cellulitis is a significant health burden because it is associated with increased hospitalization rates and medical costs. If prompt treatment is not given, it can lead to severe infection or sepsis. A holistic therapy is required, including controlling the predisposing factors, maintaining hygiene, symptomatic therapies, and antibiotics to prevent reinfection and improve the outcomes of cellulitis. Risk factor control and hygiene maintenance are crucial since they are effective preventive measures and long-term management of cellulitis, leading to patients’ improved health conditions and quality of life, also lowering the incidence of cellulitis and health burdens.
References
Boettler, M. A., Kaffenberger, B. H., & Chung, C. G. (2022). Cellulitis: A review of current practice guidelines and differentiation from pseudocellulitis. American Journal of Clinical Dermatology, 23(2), 153–165. https://doi.org/10.1007/s40257-021-00659-8
Cannon, B., & Nedergaard, J. (2004). Brown adipose tissue: Function and physiological significance. Physiological Reviews, 84(1), 277–359. https://doi.org/10.1152/physrev.00015.2003
Chuang, Y. C., Liu, P. Y., Lai, K. L., & Tseng, C. H. (2022). Bilateral lower limbs cellulitis: A narrative review of an overlooked clinical dilemma. International Journal of General Medicine, 15, 5567–5578. https://doi.org/10.2147/IJGM.S356852
Cranendonk, D. R., Lavrijsen, A. P. M., Prins, J. M., & Wiersinga, W. J. (2017). Cellulitis: Current insights into pathophysiology and clinical management. The Netherlands Journal of Medicine, 75(9), 366–378.
Lee, Y. H., Choi, J. H., & Kim, H. O. (2023). Clinical characteristics and outcomes of recurrent cellulitis: A multicenter retrospective study. Journal of Infection and Chemotherapy, 29(4), 345–352. https://doi.org/10.1016/j.jiac.2022.12.004
Man, M., Wakefield, J. S., Mauro, T. M., & Elias, P. M. (2022). Alterations in epidermal function in type 2 diabetes: Implications for the management of this disease. Journal of Diabetes, 14(9), 586–595. https://doi.org/10.1111/1753-0407.13303
McNamara, D. R., Miller, R. R., & Leung, V. H. (2022). Contemporary management of cellulitis: Advances and ongoing challenges. Clinical Infectious Diseases, 75(7), 1234–1242. https://doi.org/10.1093/cid/ciac212
Pandian, J. D., Padma Srivastava, M. V., Aaron, S., Ranawaka, U. K., Venketasubramanian, N., Sebastian, I. A., et al. (2023). The burden, risk factors and unique etiologies of stroke in South-East Asia region (SEAR). The Lancet Regional Health – Southeast Asia, 17, 100290. https://doi.org/10.1016/j.lansea.2023.100290
Pătrașcu, A. I., Vâță, D., Temelie-Olinici, D., Mocanu, M., Guguluș, D. L., Marinescu, M., et al. (2024). Skin lesions with loss of tissue and cutaneous-onset sepsis: The skin infection-sepsis relationship. Diagnostics, 14(6), 659. https://doi.org/10.3390/diagnostics14060659
Phoenix, G., Das, S., & Joshi, M. (2012). Diagnosis and management of cellulitis. BMJ, 345, e4955. https://doi.org/10.1136/bmj.e4955
Polk, C., Sampson, M. M., Roshdy, D., & Davidson, L. E. (2021). Skin and soft tissue infections in patients with diabetes mellitus. Infectious Disease Clinics of North America, 35(1), 183–197. https://doi.org/10.1016/j.idc.2020.10.007
Tan, R., Lim, J. Y., & Ng, T. M. (2021). Risk factors and prevention strategies for recurrent lower limb cellulitis: A systematic review. International Journal of Dermatology, 60(12), 1485–1494. https://doi.org/10.1111/ijd.15612
Teasdale, E. J., Lalonde, A., Muller, I., Chalmers, J., Smart, P., Hooper, J., et al. (2019). Patients’ understanding of cellulitis and views about how best to prevent recurrent episodes: Mixed‐methods study in primary and secondary care. British Journal of Dermatology, 180(4), 810–820. https://doi.org/10.1111/bjd.17445
Wang, B. Y., Yang, S. F., Ting, K. H., Wang, Y. H., Chou, M. C., & Yeh, C. B. (2023). Evaluation of the risk factors for cellulitis among patients with peripheral artery disease. Medicina, 59(5), 933. https://doi.org/10.3390/medicina59050933
Zacay, G., Hershkowitz Sikron, F., & Heymann, A. D. (2021). Glycemic control and risk of cellulitis. Diabetes Care, 44(2), 367–372. https://doi.org/10.2337/dc19-1393
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jurnal Kesehatan Amanah

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.





